EUVIMEDEUVIMED entdecken
Crossref

Spray dried lipid nanoparticle formulations enable intratracheal delivery of mRNA

Kristina Pagh Friis, Sandra Gracin, Steven Oag, Alexandra Leijon, Elin Sand, Botilda Lindberg, Elisa Lázaro-Ibáñez, Johnny Lindqvist, Kathryn A Whitehead, Annette Bak

Journal of Controlled Release · 2023-11 · 363 · 389-401

DOI: 10.1016/j.jconrel.2023.09.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-11. Verfasst von Kristina Pagh Friis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, Sweden. Electronic address: Kristina.Friis@astrazeneca.com. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Nanoparticles. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA therapies have recently taken a giant leap forward with the approval of Onpattro™, a siRNA therapy delivered using a lipid nanoparticle (LNP), and the LNP-enabled mRNA vaccines against COVID-19, which are the first mRNA drugs to reach the marketplace. The latter medicines have illustrated that stability is a significant challenge in the distribution of RNA drugs using non-viral delivery systems, particularly in areas without cold chain storage. Here, we describe a proof-of-concept study on the engineering of an LNP mRNA formulation suitable for spray drying. This process produced a dry powder formulation that maintained stability and preserved mRNA functionality with increased performance compared to liquid formulations stored two weeks at 4 °C. Intratracheal delivery of spray dried LNPs loaded with eGFP mRNA to rats resulted in the production of the eGFP protein in a range of cell types including bronchiolar epithelial cells, macrophages and type II pneumocytes; cell types involved in adaptive immunity and which would be valuable targets for inhaled vaccines against respiratory pathogens. Together, these data show that spray drying of LNPs enhances their stability and may enable RNA delivery to the lung for protein replacement therapy, gene editing, vaccination, and beyond.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesNanoparticlesRatsAnimalsHumansRNA, MessengerLiposomes

Stichwörter der Autor:innen

Drug deliveryInhalationLipid nanoparticlesRNA therapeuticsSpray dryingmRNA

Substanzen

Lipid NanoparticlesRNA, MessengerCOVID-19 VaccinesLiposomes

Autor:innen und Institutionen

  • Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, Sweden. Electronic address: Kristina.Friis@astrazeneca.com.
  • Inhalation Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden.
  • Animal Sciences & Technology, Clinical Pharmacology and Safety Sciences, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • R&I Safety, Clinical Pharmacology and Safety Sciences, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Imaging and Data Analytics, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Bioscience Cough & In Vivo, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, Sweden.

Zitieren

APA

Friis, K. P., Gracin, S., Oag, S., Leijon, A., Sand, E., Lindberg, B., Lázaro-Ibáñez, E., Lindqvist, J., Whitehead, K. A., & Bak, A. (2023). Spray dried lipid nanoparticle formulations enable intratracheal delivery of mRNA. Journal of Controlled Release, 363, 389-401. https://doi.org/10.1016/j.jconrel.2023.09.031

Vancouver

Friis KP, Gracin S, Oag S, Leijon A, Sand E, Lindberg B, et al. Spray dried lipid nanoparticle formulations enable intratracheal delivery of mRNA. Journal of Controlled Release. 2023;363:389-401. doi:10.1016/j.jconrel.2023.09.031

BibTeX
@article{Friis2023,
  author = {Friis, Kristina Pagh and Gracin, Sandra and Oag, Steven and Leijon, Alexandra and Sand, Elin and Lindberg, Botilda and Lázaro-Ibáñez, Elisa and Lindqvist, Johnny and Whitehead, Kathryn A and Bak, Annette},
  title = {Spray dried lipid nanoparticle formulations enable intratracheal delivery of mRNA},
  journal = {Journal of Controlled Release},
  year = {2023},
  volume = {363},
  pages = {389--401},
  doi = {10.1016/j.jconrel.2023.09.031}
}
Kostenlos starten →